Loading reports catalog...
Loading reports catalog...
Access deep-dive research across global industry sectors to empower your strategic decision-making with data-driven insights.
Explore our comprehensive collection of healthcare market research reports, offering in-depth insights into the rapidly evolving global healthcare ecosystem. Our detailed analysis covers various segments, providing crucial medical device market analysis and identifying emerging trends across pharmaceuticals, biotechnology, and healthcare IT. As part of our specialized offerings, we provide granular data on niche sectors like the sterilization equipment market, ensuring industry leaders have the actionable intelligence needed for strategic planning and competitive benchmarking. Our reports deliver precise market sizing, growth forecasts, and competitive landscape assessments to guide your business decisions in the dynamic healthcare industry.
Showing 126 Results
The U.S. pulmonary drug delivery devices market size was estimated at USD 23.7 billion in 2025 and is expected to expand at a CAGR of 4.9% from USD 24.7 billion in 2026 to USD 37.8 billion in 2035. The robust market growth is driven by the rising prevalence of respiratory diseases, increasing demand for targeted drug delivery, technological advancements in inhalation devices, and growing adoption of patient-friendly treatment options.
The U.S. surgical equipment market size was evaluated at USD 7.9 billion in 2025 and is expected to grow at a CAGR of 7.9% from USD 8.5 billion in 2026 to USD 16.7 billion in 2035. The market is witnessing consistent expansion, fueled by the increasing number of surgical procedures, the escalating prevalence of chronic illnesses, innovations in surgical technology, and heightened funding for healthcare facilities.
The U.S. iliac stents market was evaluated at USD 464.71 million in 2025 and is projected to grow at a CAGR of 6.3% from USD 489.85 million in 2026 to USD 845.97 million in 2035. The market growth is primarily driven by the increasing prevalence of iliac artery occlusive disease and peripheral arterial disease, leading to a higher demand for endovascular interventions to restore blood flow and reduce vascular complications. Furthermore, continuous advancements in stent design and delivery systems, rising preference for minimally invasive vascular procedures, and the growing adoption of image-guided treatment approaches are contributing to the expansion of the U.S. iliac stents market.
The U.S. hyaluronic acid-based dermal fillers market was evaluated at USD 1.8 billion in 2025 and is projected to grow at a CAGR of 9.7% from USD 1.9 billion in 2026 to USD 4.4 billion in 2035. The market expansion is primarily driven by the growing preference for facial contouring and volume restoration treatments that deliver immediate aesthetic results with minimal recovery time. Additionally, increasing acceptance of cosmetic enhancements among a broader consumer base, continuous advancements in filler formulations with improved longevity and safety profiles, and the rising availability of FDA-approved injectable products are supporting the growth of the U.S. hyaluronic acid-based dermal fillers market.
The U.S. hospital gowns market was evaluated at USD 1.2 billion in 2025 and is projected to grow at a CAGR of 6.8% from USD 1.2 billion in 2026 to USD 2.2 billion in 2035. The market growth is mainly attributed to the rising volume of inpatient admissions, increasing number of surgical interventions, and growing emphasis on maintaining hygienic healthcare environments. Furthermore, the heightened focus on patient and healthcare worker safety, increasing adoption of protective medical apparel to reduce infection transmission risks, and continuous investments in healthcare facilities and medical infrastructure are contributing to the expansion of the U.S. hospital gowns market.
The U.S. hemodialysis catheters market was evaluated at USD 373.56 million in 2025 and is projected to grow at a CAGR of 5.6% from USD 390.93 million in 2026 to USD 638.31 million in 2035. The market expansion is primarily driven by the rising incidence of chronic kidney disease and end-stage renal disease, increasing the need for reliable vascular access during dialysis procedures. Additionally, ongoing advancements in catheter materials and design, growing utilisation of long-term dialysis treatments, and the extensive presence of dialysis centers and renal care facilities are supporting the growth of the U.S. hemodialysis catheters market.
Stay informed with updates on related market reports and key industry topics.